In March 2025, the company declared new ideas for the direct-to-consumer giving of its Wegovy weight loss drug. The company founded a completely new pharmacy, identified as NovoCare, which would cost consumers $499 every month for use of the drug, under 50 % the cost of the drug by means of other pharmaceutical distribution networks.[53]Noteworthy